Clinical Trials Browser

Withdrawn × mirvetuximab soravtansine × Clear all

NCT03836157 2019-06-27

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Phase 2 Withdrawn

Endometrial Neoplasms

NCT03045393 2018-07-05

IMGN853

Phase 1 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms